跳至主要内容
临床试验/NCT04446897
NCT04446897已完成1 期

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction Immobilised on a Biodegradable Carrier

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年8月3日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
number of patients cured

研究概览

简要总结

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

详细描述

The bone defect will be filled with a porous membrane based on bone collagen measuring 5x5 mm or more with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
70 Years 至 70 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic medium-severe periodontitis

排除标准

  • pregnancy
  • breast-feeding
  • acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
  • mental disorders

研究组 & 干预措施

mesenchymal stem cells

Experimental

standard treatment according to clinical protocols plus mesenchymal stem cells

干预措施: mesenchymal stem cells (Biological)

结局指标

主要结局

number of patients cured

时间窗: 1 month

number of patients cured

次要结局

未报告次要终点

研究者

研究点 (2)

Loading locations...

相似试验